Kuros Biosciences Ag Stock Probability of Future Pink Sheet Price Finishing Under 6.27

CSBTF Stock  USD 21.40  3.90  15.42%   
Kuros Biosciences' future price is the expected price of Kuros Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kuros Biosciences AG performance during a given time horizon utilizing its historical volatility. Check out Kuros Biosciences Backtesting, Kuros Biosciences Valuation, Kuros Biosciences Correlation, Kuros Biosciences Hype Analysis, Kuros Biosciences Volatility, Kuros Biosciences History as well as Kuros Biosciences Performance.
  
Please specify Kuros Biosciences' target price for which you would like Kuros Biosciences odds to be computed.

Kuros Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kuros Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kuros Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kuros Biosciences generated a negative expected return over the last 90 days
Kuros Biosciences has high historical volatility and very poor performance
The company reported the revenue of 13.81 M. Net Loss for the year was (7.54 M) with profit before overhead, payroll, taxes, and interest of 10.07 M.
Kuros Biosciences AG has accumulated about 28.62 M in cash with (5.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.87.
Roughly 35.0% of the company shares are held by company insiders

Kuros Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kuros Pink Sheet often depends not only on the future outlook of the current and potential Kuros Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kuros Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding32.8 M
Shares Float21.6 M

Kuros Biosciences Technical Analysis

Kuros Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Kuros Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kuros Biosciences AG. In general, you should focus on analyzing Kuros Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Kuros Biosciences Predictive Forecast Models

Kuros Biosciences' time-series forecasting models is one of many Kuros Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kuros Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Kuros Biosciences

Checking the ongoing alerts about Kuros Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kuros Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kuros Biosciences generated a negative expected return over the last 90 days
Kuros Biosciences has high historical volatility and very poor performance
The company reported the revenue of 13.81 M. Net Loss for the year was (7.54 M) with profit before overhead, payroll, taxes, and interest of 10.07 M.
Kuros Biosciences AG has accumulated about 28.62 M in cash with (5.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.87.
Roughly 35.0% of the company shares are held by company insiders

Other Information on Investing in Kuros Pink Sheet

Kuros Biosciences financial ratios help investors to determine whether Kuros Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kuros with respect to the benefits of owning Kuros Biosciences security.